Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
Price:
2 307.25 INR
-1.83%
Updated:
May 3, 2024
Dr. Lal PathLabs Ltd
Cash from Financing Activities
|
Dr. Lal PathLabs Ltd
Cash from Financing Activities Peer Comparison
Comparables:
526783
THYROCARE
VIJAYA
KRSNAA
METROPOLIS
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
|
Cash from Financing Activities
-₹2.8B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dr Agarwal's Eye Hospital Ltd
BSE:526783
|
Cash from Financing Activities
-₹16.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Thyrocare Technologies Ltd
NSE:THYROCARE
|
Cash from Financing Activities
-₹802.1m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vijaya Diagnostic Centre Ltd
NSE:VIJAYA
|
Cash from Financing Activities
-₹419.1m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Krsnaa Diagnostics Ltd
NSE:KRSNAA
|
Cash from Financing Activities
-₹331.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Metropolis Healthcare Ltd
NSE:METROPOLIS
|
Cash from Financing Activities
-₹2.9B
|
CAGR 3-Years
-74%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
See Also
What is Dr. Lal PathLabs Ltd's Cash from Financing Activities?
Cash from Financing Activities
-2.8B
INR
-2.8B
INR
Based on the financial report for Dec 31, 2023, Dr. Lal PathLabs Ltd's Cash from Financing Activities amounts to -2.8B INR.
What is Dr. Lal PathLabs Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-21%
-21%
The average annual Cash from Financing Activities growth rates for Dr. Lal PathLabs Ltd have been -21% over the past three years .
You don't have any saved screeners yet
